Niepubliczny Zaklad Opieki Zdrowotnej Centrum Medyczne Promimed Sp. z o.o. sp.k.

At Niepubliczny Zaklad Opieki Zdrowotnej Centrum Medyczne Promimed Sp. z o.o. sp.k. in Cracow, gastroenterology research includes studies focused on ulcerative colitis and related inflammatory conditions. These trials are designed to assess whether new treatment approaches can improve symptoms, support healing of the bowel lining, and strengthen overall disease control.

• Study of moderately to severely active ulcerative colitis with a focus on endoscopic improvement and symptom relief
• Evaluation of therapies aimed at better controlling immune-mediated digestive inflammation

The research reflects a strong interest in improving care for patients with chronic intestinal inflammation through more effective and better-tolerated treatment options.

The site also supports research in respiratory medicine, especially for people living with chronic obstructive pulmonary disease and asthma. These trials are exploring new inhaled and add-on therapies to reduce flare-ups, improve breathing function, and compare how well different treatment options work in everyday disease management.

• Research in COPD aimed at lowering exacerbations and improving lung function
• Trials in moderate to severe asthma assessing safety and airway response to different inhaled formulations

This area of work is centered on testing treatments that may help patients breathe more easily and maintain better long-term respiratory stability.

Clinical research at this hospital/clinic extends into immune-related disorders, including rheumatoid arthritis and systemic lupus erythematosus. The studies are intended to evaluate treatment effectiveness, safety, and immune control in chronic conditions that can affect joints, organs, and overall quality of life.

• Assessment of treatment response in moderate to severe rheumatoid arthritis
• Long-term safety research in systemic lupus erythematosus

These trials contribute to a broader effort to improve care for autoimmune diseases by identifying therapies that may better balance disease control with tolerability.